Tsuyoshi Okada

Shimotsuke, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Dexmedetomidine attenuates methamphetamine-induced hyperthermia and hyperlocomotion in male rats and modulates monoamine dynamics in the anterior hypothalamus.

Dexmedetomidine attenuates methamphetamine-induced hyperthermia and hyperlocomotion in male rats and modulates monoamine dynamics in the anterior hypothalamus.

Journal: Psychopharmacology

Published: June 19, 2026

Comparative effects of antidepressants on cocaine-induced hyperthermia in rats: a preclinical study.

Comparative effects of antidepressants on cocaine-induced hyperthermia in rats: a preclinical study.

Journal: Neuroscience letters

Published: July 19, 2025

Modulation of tramadol-induced hyperthermia by risperidone and ambient temperature in rats.

Modulation of tramadol-induced hyperthermia by risperidone and ambient temperature in rats.

Journal: Toxicology and applied pharmacology

Published: June 04, 2025

The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatment.

The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatment.

Journal: Neuropsychopharmacology reports

Published: September 14, 2024

Risperidone suppresses caffeine-induced hyperthermia and hyperactivity in rats.

Risperidone suppresses caffeine-induced hyperthermia and hyperactivity in rats.

Journal: Neuroscience letters

Published: March 12, 2024

Suicide of living kidney donor after recipient's graft organ failure: A case report.

Suicide of living kidney donor after recipient's graft organ failure: A case report.

Journal: PCN reports : psychiatry and clinical neurosciences

Published: November 21, 2023

Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in Japan.

Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in Japan.

Journal: Journal of clinical psychopharmacology

Published: May 22, 2023

Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project.

Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project.

Journal: BMC psychiatry

Published: March 12, 2023

Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.

Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.

Journal: Psychiatry and clinical neurosciences

Published: February 22, 2023

Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia.

Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia.

Journal: Journal of clinical psychopharmacology

Published: October 04, 2022

Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project.

Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project.

Journal: Neuropsychopharmacology reports

Published: August 01, 2022

Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders.

Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders.

Journal: Neuropsychopharmacology reports

Published: July 31, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026